ARCHIVES

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

CCRAC Cool to Three Psychosocial Proposals, Approves One On Aging

October 26, 1979

Moffitt To Enhance Information For Brain Tumor Patients.

July 13, 2001

Bypass Budget for FY 1989 to Ask $2 Billion For NCI, With Projection To $3 Billion by 1993

May 29, 1987

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

Otis Brawley To Succeed Harmon Eyre As American Cancer Society’s Chief Medical Officer.

August 3, 2007

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982